Diagnostics company 20/20 GeneSystems presented data last week showing high sensitivity and specificity for its protein biomarker test to predict response to Herceptin (trastuzumab) in HER2-positive breast cancer patients.
NEW YORK (GenomeWeb News) – The British non-profit Parkinson's UK plans to provide £750,000 ($1.2 million) for research to find protein biomarkers for diagnosing and measuring the progress of Parkinson's disease.
NEW YORK (GenomeWeb News) – Isogen Life Science will distribute Axela's multiplex biomarker platforms in Benelux and Spain under an agreement announced by the firms today.
NEW YORK (GenomeWeb News) – BG Medicine reported a 44 percent drop in first-quarter revenues year over year as its service revenues plummeted but its product revenues rose sharply.
NEW YORK (GenomeWeb News) – Opko Health today announced it has granted UK-based International Health Technology the rights to offer a novel panel of protein biomarkers and an associated algorithm in parts of Europe for the detection of prostate cancer.
NEW YORK (GenomeWeb News) – Denator and two Dutch medical centers today announced a collaboration to develop a biomarker discovery platform for the diagnosis of cancer.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Pressure BioSciences and Target Discovery today announced they have expanded a technology license and supply agreement.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Provista Diagnostics today announced it has entered into purchase agreements with institutional investors to raise $5 million in a Series A Preferred financing.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – EMD Millipore and Proteomic International have signed a collaborative agreement to validate biomarkers related to diabetic nephropathy, the firms said today.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Amarantus BioSciences today said that it has licensed exclusive, worldwide rights from Power3 Medical Products to a test for Parkinson's disease diagnosis.
In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.
